Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Basel Medical GroupBMGL -24.94%17 PS Ratio is 0.85 as of Jul. 16, 2026, which is 72% below its 10-year median of 3.00. GuruFocus rates BMGL with a GF Score™ of 17/100. The stock has 3 warning signs investors should review. Among 661 Healthcare Providers & Services companies, Basel Medical Group ranks better than 68.08% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Basel Medical Group's share price is $6.14.
Basel Medical Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $7.22. Hence, Basel Medical Group's PS Ratio for today is 0.85.
Good Sign:
Basel Medical Group Ltd stock PS Ratio (=1.09) is close to 2-year low of 1.09.
The historical rank and industry rank for Basel Medical Group's PS Ratio or its related term are showing as below:
BMGL'
s PS Ratio Range Over the Past 10 Years
Min: 0.85 Med: 3 Max: 15.09
Current: 0.85
During the past 4 years, Basel Medical Group's highest PS Ratio was 15.09. The lowest was 0.85. And the median was 3.00.
BMGL's PS Ratio is ranked better than 68.08% of 661
companies
in the Healthcare Providers & Services industry
Industry Median: 1.51
vs BMGL: 0.85
During the past 4 years, Basel Medical Group's highest 3-Year average Revenue per Share Growth Rate was -0.30% per year. The lowest was -0.30% per year. And the median was -0.30% per year.
Back to Basics: PS Ratio
Basel Medical Group (NAS:BMGL) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Basel Medical Group PS Ratio Related Terms
Basel Medical Group PS Ratio Historical Data
* Premium members only.
The historical data trend for Basel Medical Group's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Basel Medical Group's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Basel Medical Group PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Basel Medical Group's PS Ratio distribution charts can be found below:
* The bar in red indicates where Basel Medical Group's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Basel Medical Group's Share Price of today is $6.14.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Basel Medical Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $7.22.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Basel Medical Group (BMGL) has a PS Ratio of 0.85 as of Jul. 16, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Basel Medical Group and its competitors. This is 72% below median its historical median of 3.00. Over the past decade, Basel Medical Group's PS Ratio has ranged from 0.85 to 15.09. According to the industry distribution chart, Basel Medical Group ranks #211 out of 661 companies in the Healthcare Providers & Services industry, placing it in the top 31.9%.
Is Basel Medical Group's PS Ratio too high?
Basel Medical Group's current PS Ratio of 0.85 is 72% below median its 10-year median of 3.00. Over the past 10 years, this metric has ranged from a low of 0.85 to a high of 15.09. The Healthcare Providers & Services industry median PS Ratio is 1.51. Basel Medical Group's value of 0.85 is 43.7% below this industry median. Based on the distribution chart, Basel Medical Group ranks #211 out of 661 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Basel Medical Group has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Basel Medical Group's PS Ratio compare to AMS and HLYK?
According to the Healthcare Providers & Services industry distribution chart, Basel Medical Group ranks #211 out of 661 companies for PS Ratio. This puts Basel Medical Group in the upper half of its industry. The industry median PS Ratio is 1.51. Basel Medical Group's value of 0.85 is 43.7% below this benchmark. Historically, Basel Medical Group's own PS Ratio has ranged from 0.85 to 15.09 over the past decade. While the company's 10-year median is 3.00 vs. the industry median of 1.51, Basel Medical Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.51, based on 661 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Basel Medical Group's current PS Ratio of 0.85 is 43.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Basel Medical Group and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Basel Medical Group's current PS Ratio is 0.85, which is 72% below median its own 10-year median of 3.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Basel Medical Group stock overvalued right now?
Basel Medical Group (BMGL) has a current PS Ratio of 0.85. The current PS Ratio is 0.85, which is 72% below median its 10-year median of 3.00 and 43.7% below the Healthcare Providers & Services industry median of 1.51. Basel Medical Group's overall GF Score™ is 17/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Basel Medical Group (BMGL), the current PS Ratio is 0.85 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Basel Medical Group Ltd provides general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. The services provided by clinics include, but are not limited to, consultation, medical diagnosis and medical or surgical treatments for orthopedic, trauma, sports medicine, general practice, health screening, mental health, women's health and neurosurgical conditions and clinics are equipped with the facilities needed to perform a variety of procedures on site and minor surgical services. Key revenue is generated from Singapore.
17GF Score
Get the complete analysis for BMGL
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BMGL has been successfully added to your 
